Revvity, Inc. (RVTY) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RVTY Revenue Growth
Revenue Breakdown (FY 2025)
RVTY's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
RVTY Revenue Analysis (2014–2025)
As of May 8, 2026, Revvity, Inc. (RVTY) generated trailing twelve-month (TTM) revenue of $2.90 billion, reflecting solid growth of +7.0% year-over-year. The most recent quarter (Q1 2026) recorded $711.1 million in revenue, down 7.9% sequentially.
Looking at the longer-term picture, RVTY's 5-year compound annual growth rate (CAGR) stands at -5.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $3.83 billion in 2021.
Revenue diversification analysis shows RVTY's business is primarily driven by Life Sciences (50%), and Diagnostics (50%). With over half of revenue concentrated in Life Sciences, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including WAT (+26.4% YoY), BRKR (+0.4% YoY), and MTD (+6.8% YoY), RVTY has underperformed the peer group in terms of revenue growth. Compare RVTY vs WAT →
RVTY Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RVTYCurrent | $2.9B | +7.0% | -5.5% | 12.5% | |
 WAT | $3.2B | +26.4% | +6.0% | 28.2% | |
 BRKR | $3.4B | +0.4% | +11.6% | 6.9% | |
 MTD | $4.0B | +6.8% | +5.5% | 27.8% | |
 BIO | $2.6B | +1.9% | +0.3% | 10.5% | |
 HOLX | $4.1B | +2.2% | +1.7% | 17.4% |
RVTY Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.86B | +3.7% | $1.52B | 53.1% | $356.6M | 12.5% |
| 2024 | $2.76B | +0.2% | $1.32B | 48.0% | $410.5M | 14.9% |
| 2023 | $2.75B | -16.9% | $1.32B | 48.1% | $399.5M | 14.5% |
| 2022 | $3.31B | -13.5% | $1.76B | 53.2% | $781.1M | 23.6% |
| 2021 | $3.83B | +1.2% | $2.28B | 59.6% | $1.34B | 35.0% |
| 2020 | $3.78B | +31.2% | $1.99B | 52.6% | $1.02B | 27.0% |
| 2019 | $2.88B | +3.8% | $1.29B | 44.8% | $405.5M | 14.1% |
| 2018 | $2.78B | +23.1% | $1.25B | 45.0% | $371.0M | 13.4% |
| 2017 | $2.26B | +6.7% | $1.03B | 45.6% | $304.6M | 13.5% |
| 2016 | $2.12B | +0.5% | $972.3M | 46.0% | $305.7M | 14.4% |
Full RVTY Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RVTY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RVTY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RVTY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRVTY — Frequently Asked Questions
Quick answers to the most common questions about buying RVTY stock.
Is RVTY's revenue growth accelerating or slowing?
RVTY maintains +7.0% revenue growth, in line with its 5-year CAGR of -5.5%. TTM revenue stands at $2.9B. Growth rate remains consistent with historical average.
What is RVTY's long-term revenue growth rate?
Revvity, Inc.'s 5-year revenue CAGR of -5.5% reflects the sustained expansion pattern. Current YoY growth of +7.0% is near this long-term average.
How is RVTY's revenue distributed by segment?
RVTY reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.